Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 1
2016 1
2017 2
2018 1
2019 3
2020 5
2021 10
2022 5
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis.
Okusaka T, Nakamura M, Yoshida M, Kitano M, Ito Y, Mizuno N, Hanada K, Ozaka M, Morizane C, Takeyama Y; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society. Okusaka T, et al. Int J Clin Oncol. 2023 Apr;28(4):493-511. doi: 10.1007/s10147-023-02317-x. Epub 2023 Mar 15. Int J Clin Oncol. 2023. PMID: 36920680 Free PMC article.
Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial).
Okada KI, Kimura K, Yamashita YI, Shibuya K, Matsumoto I, Satoi S, Yoshida K, Kodera Y, Akahori T, Hirono S, Eguchi H, Asakuma M, Tani M, Hatano E, Ikoma H, Ohira G, Hayashi H, Wan K, Shimokawa T, Kawai M, Yamaue H; NAC‐GA investigators. Okada KI, et al. Among authors: shibuya k. Ann Gastroenterol Surg. 2023 Jul 8;7(6):997-1008. doi: 10.1002/ags3.12712. eCollection 2023 Nov. Ann Gastroenterol Surg. 2023. PMID: 37927936 Free PMC article.
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis.
Yamada S, Fujii T, Yamamoto T, Takami H, Yoshioka I, Yamaki S, Sonohara F, Shibuya K, Motoi F, Hirano S, Murakami Y, Inoue H, Hayashi M, Hashimoto D, Murotani K, Kitayama J, Ishikawa H, Kodera Y, Sekimoto M, Satoi S. Yamada S, et al. Among authors: shibuya k. J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S110-S117. doi: 10.21037/jgo-20-243. J Gastrointest Oncol. 2021. PMID: 33968431 Free PMC article.
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study).
Ikenaga N, Hashimoto T, Mizusawa J, Kitabayashi R, Sano Y, Fukuda H, Nakata K, Shibuya K, Kitahata Y, Takada M, Kamei K, Kurahara H, Ban D, Kobayashi S, Nagano H, Imamura H, Unno M, Takahashi A, Yagi S, Wada H, Shirakawa H, Yamamoto N, Hirono S, Gotohda N, Hatano E, Nakamura M, Ueno M; on behalf of the Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology Group. Ikenaga N, et al. Among authors: shibuya k. BMC Cancer. 2024 Feb 19;24(1):231. doi: 10.1186/s12885-024-11957-9. BMC Cancer. 2024. PMID: 38373949 Free PMC article. Clinical Trial.
Perioperative C-peptide index is associated with the status of diabetes management after pancreatectomy.
Shikata M, Chujo D, Enkaku A, Takikawa-Nishida A, Honoki H, Yamada-Matsukoshi S, Nakagawa-Yokoyama M, Kamigishi M, Inagawa S, Fujisaka S, Yagi K, Shibuya K, Fujii T, Tobe K. Shikata M, et al. Among authors: shibuya k. J Diabetes Investig. 2022 Oct;13(10):1685-1694. doi: 10.1111/jdi.13861. Epub 2022 Jun 28. J Diabetes Investig. 2022. PMID: 35638355 Free PMC article.
Prognostic significance of KLF4 expression in gastric cancer.
Hashimoto I, Nagata T, Sekine S, Moriyama M, Shibuya K, Hojo S, Matsui K, Yoshioka I, Okumura T, Hori T, Shimada Y, Tsukada K. Hashimoto I, et al. Among authors: shibuya k. Oncol Lett. 2017 Feb;13(2):819-826. doi: 10.3892/ol.2016.5499. Epub 2016 Dec 14. Oncol Lett. 2017. PMID: 28356964 Free PMC article.
Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer.
Kimura N, Yamada S, Takami H, Murotani K, Yoshioka I, Shibuya K, Sonohara F, Hoshino Y, Hirano K, Watanabe T, Baba H, Mori K, Miwa T, Kanda M, Hayashi M, Matsui K, Okumura T, Kodera Y, Fujii T. Kimura N, et al. Among authors: shibuya k. Cancers (Basel). 2020 Dec 24;13(1):36. doi: 10.3390/cancers13010036. Cancers (Basel). 2020. PMID: 33374369 Free PMC article.
Survival of detached cancer cells is regulated by movement of intracellular Na+,K+-ATPase.
Fujii T, Shimizu T, Katoh M, Nagamori S, Koizumi K, Fukuoka J, Tabuchi Y, Sawaguchi A, Okumura T, Shibuya K, Fujii T, Takeshima H, Sakai H. Fujii T, et al. Among authors: shibuya k. iScience. 2021 Apr 15;24(5):102412. doi: 10.1016/j.isci.2021.102412. eCollection 2021 May 21. iScience. 2021. PMID: 33997694 Free PMC article.
42 results